Dxlasmart 30 Capsule MR
Marketer
Evolan Pharmaceuticals Pvt Ltd.
Salt Composition
Dexlansoprazole (30mg)
Overview Dxlasmart 30 Capsule MR
Gastro-acid reducer Acidorin 30 MR capsules lessen stomach acid production. Indicated for stomach and intestinal acid-related disorders like heartburn and acid reflux, Acidorin 30 MR is administered intravenously by a healthcare professional as directed. Dosage is condition-specific, aiming for the lowest effective dose for the shortest duration. Therapeutic effects may take several weeks; continued use as prescribed, even with symptom resolution, is crucial. Long-term use may necessitate regular magnesium level monitoring due to potential depletion. Common, generally mild, side effects include nausea, vomiting, abdominal pain, diarrhoea, and malaise. Persistent or bothersome side effects warrant medical consultation. The risk of side effects increases with prolonged use. While rare, some serious side effects necessitate immediate medical attention – consult your physician for specifics. Prolonged use may increase fracture risk. Dietary modifications, such as avoiding rich, spicy, and fatty foods, caffeinated beverages, and alcohol, are recommended. Acidorin 30 MR is contraindicated in individuals with severe liver disease, those on HIV medications, those with a history of similar medication allergies, or osteoporosis. While alcohol doesn't directly interact with Acidorin 30 MR, its acid-stimulating effect should be considered. Dizziness, drowsiness, or visual disturbances may occur, precluding driving, cycling, or operating machinery until symptoms subside. Use during pregnancy and breastfeeding is generally discouraged.
Primary Ingredients of Dxlasmart 30 Capsule MR
No text provided to rephrase.
Uses of Dxlasmart 30 Capsule MR
Acid indigestion and gastroesophageal reflux (GERD)
Major Benefits of Dxlasmart 30 Capsule MR:
Follow your doctor's instructions precisely regarding dosage and treatment length for Dxlasmart 30 MR Capsules. Ingest the capsule whole; do not crush, chew, or break it. Administer on an empty stomach.
Common Side effects of Dxlasmart 30 Capsule MR:
- Nausea
- Abdominal pain
- Flatulence
- Diarrhea
- Vomiting
How to use Dxlasmart 30 Capsule MR:
Follow your physician's instructions precisely regarding dosage and treatment length for Dxlasmart 30 MR Capsules. Ingest the capsule whole; avoid chewing, crushing, or breaking it. Administer on an empty stomach.
How Dxlasmart 30 Capsule MR works:
Acid reflux and indigestion find relief with Dxlasmart 30 MR Capsules, a medication classified as a proton pump inhibitor (PPI). This medicine lessens stomach acid production, providing symptomatic relief.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol while taking Dxlasmart 30 Capsule MR is inadvisable.
PregnancyCONSULT YOUR DOCTOR
Data on the use of Dxlasmart 30 MR Capsules in pregnancy is lacking. Seek medical advice from your physician.
Breast feedingCONSULT YOUR DOCTOR
Data on the compatibility of Dxlasmart 30 Capsule MR with breastfeeding is currently lacking. Seek medical advice from your physician.
DrivingCONSULT YOUR DOCTOR
The effect of Dxlasmart 30 Capsule MR on driving ability is unknown. Refrain from driving if you experience symptoms impairing concentration or reaction time.
KidneySAFE IF PRESCRIBED
The extended-release Dxlasmart 30 Capsule can be used safely by individuals with kidney impairment; no alteration to the prescribed dosage is necessary.
LiverCAUTION
Individuals with hepatic impairment should exercise caution when using Dxlasmart 30 MR capsules. Dosage modification of Dxlasmart 30 MR capsules may be necessary. Physician consultation is advised.
What if you forget to take Dxlasmart 30 Capsule MR :
Should you forget a dose of Dxlasmart 30 MR Capsule, take it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Dxlasmart 30 Capsule MR
| Label | Value |
|---|---|
| Chemical Classification | Benzimidazole Sulfoxide |
| Developing Habits | No. |
| Treatment Category | Gastrointestinal system |


